Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Tocilizumab in Patients With Active Moderate-to-Severe Corticosteroid-Resistant Thyroid Eye Disease: Open, Prospective, Observational Study

NCT06367517 is registered in ClinicalTrials.gov with Medical University of Warsaw as lead sponsor.

NCT NCT06367517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06367517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Tocilizumab in Patients With Active Moderate-to-Severe Corticosteroid-Resistant Thyroid Eye Disease: Open, Prospective, Observational Study
Lead sponsor
Medical University of Warsaw
Phase
Observational
Overall status
Completed
Start date
May 20, 2021
Completion date
May 20, 2025
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ophthalmopathy, orbitopathy, graves, thyroid eye disease